Nanolive raised $20 million series C backed by Taiwania Capital
30 March 2022
30 March 2022
Total investments received (USD): 22.2m
Round value (USD): 20m
Round investors:
Swisscom Ventures
Taiwania Capital
Company: Nanolive
Related deals
Kinarus secured CHF 20 million in a convertible note backed by YA II PN of Yorkville Advisors
Investments
20 August 2022
Vector BioPharma raised $30 million series A round led by Versant Ventures.
Investments
02 August 2022
Memo Therapeutics closed a Series B financing round of CHF37 million.
Investments
14 February 2022
Medimaps raised $20 million
Investments
08 December 2021
ORIGYN Foundation raised $20 million
Investments
20 November 2021
Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom